Quinoa Seed Oil (Chenopodium quinoa)

Quinoa seed oil is extracted from Chenopodium quinoa seeds and is rich in unsaturated fatty acids—particularly linoleic acid (omega-6) and alpha-linolenic acid (omega-3)—along with phytosterols such as beta-sitosterol and squalene. These bioactives modulate lipid metabolism by inhibiting hepatic cholesterol synthesis and reducing intestinal cholesterol absorption, potentially improving cardiovascular biomarkers.

Origin & History

Quinoa seed oil is extracted from the seeds of Chenopodium quinoa, an annual plant native to the Andean region of South America. The oil is obtained through cold pressing or solvent extraction methods, yielding a lipid-rich fraction containing high levels of unsaturated fatty acids that vary by quinoa genotype (black, white, red varieties).

Historical & Cultural Context

Quinoa seeds have been used for over 5,000 years by Andean indigenous peoples (Inca, Aymara, Quechua cultures) as a staple food for nutrition and endurance. However, no documented traditional medicinal use of the seed oil specifically was identified in historical records.

Health Benefits

• May reduce triglyceride levels - Evidence from quinoa seed studies (not oil specifically) showed reductions of 6.86 mg/dL in meta-analysis (PMID: 33037704)
• Potential LDL cholesterol reduction - Quinoa seed consumption lowered LDL by 3.08 mg/dL in meta-analysis of RCTs (PMID: 33037704)
• Possible metabolic syndrome support - 40% reduction in metabolic syndrome prevalence with 25g/d quinoa seeds in one RCT (PMID: 29955719)
• Antioxidant properties - Animal studies show oil reduces ROS and protein carbonyl levels in nanoemulsion form
• Mild anti-cancer cell effects - In vitro studies show inhibition of HCT116 colon cancer cells (IC50 281.9-647.4 µg/mL)

How It Works

Quinoa seed oil's phytosterols, primarily beta-sitosterol and campesterol, competitively inhibit intestinal cholesterol absorption by displacing cholesterol from micelles in the gut lumen, reducing LDL-C uptake. Its high linoleic acid content activates peroxisome proliferator-activated receptor alpha (PPAR-α), upregulating fatty acid beta-oxidation and suppressing hepatic triglyceride synthesis via downregulation of sterol regulatory element-binding protein 1c (SREBP-1c). Squalene, a triterpene present in the oil, may additionally modulate HMG-CoA reductase activity, further attenuating endogenous cholesterol production.

Scientific Research

Clinical evidence for quinoa seed oil specifically is lacking; existing research focuses on whole quinoa seeds. A 2020 meta-analysis (PMID: 33037704) found significant triglyceride and LDL reductions from quinoa seed consumption. One RCT (n=50, PMID: 29955719) tested 25-50g/d quinoa seeds for 12 weeks in overweight adults, showing metabolic benefits at higher doses.

Clinical Summary

Most available clinical evidence derives from quinoa seed consumption studies rather than isolated quinoa seed oil trials, limiting direct extrapolation. A meta-analysis of randomized controlled trials (PMID: 33037704) found quinoa seed intake reduced triglycerides by 6.86 mg/dL and LDL cholesterol by 3.08 mg/dL, though effect sizes were modest and study sample sizes were generally small. No large-scale, oil-specific RCTs have been published as of current literature, meaning evidence quality for quinoa seed oil remains preliminary and largely mechanistic or animal-based. Independent clinical trials isolating the oil fraction are needed before definitive efficacy claims can be made.

Nutritional Profile

Quinoa seed oil is a lipid-rich extract with a distinctive fatty acid composition: linoleic acid (omega-6) is the dominant fatty acid at approximately 52-55% of total fatty acids, followed by oleic acid (omega-9) at 21-25%, palmitic acid (saturated) at 9-11%, and alpha-linolenic acid (omega-6) at 4-6%, with stearic acid at approximately 3-4%. This gives a polyunsaturated-to-saturated fat ratio of approximately 4:1, which is nutritionally favorable. Notably, quinoa seed oil contains squalene at concentrations of 0.3-0.6% (approximately 3,000-6,000 mg/kg), which is substantially higher than most vegetable oils though lower than amaranth oil; squalene is a triterpene with antioxidant and potential cholesterol-modulating properties. Tocopherol (vitamin E) content is approximately 300-700 mg/kg total, with gamma-tocopherol as the predominant form, contributing to oxidative stability and antioxidant activity. Phytosterols, including beta-sitosterol, campesterol, and stigmasterol, are present at approximately 2,000-4,000 mg/kg, which may contribute to the LDL-lowering effects observed in quinoa seed meta-analyses (PMID: 33037704). The oil contains trace amounts of ecdysteroids (e.g., 20-hydroxyecdysone), bioactive compounds associated with metabolic and anabolic effects, though concentrations in the isolated oil are lower than in whole seeds. Quinoa seed oil contains no dietary fiber, negligible protein (residual from extraction), and no significant carbohydrate content. Carotenoid pigments are present in minor quantities (~1-5 mg/kg). Bioavailability: the high PUFA content, particularly linoleic acid, is well-absorbed via standard lipid digestion pathways; however, the omega-6 predominance (high omega-6:omega-3 ratio of approximately 9-13:1) should be considered in the context of overall dietary fat balance. Squalene bioavailability from the oil matrix is considered good due to its lipophilic nature and co-delivery with other fats.

Preparation & Dosage

No clinically studied dosages exist for quinoa seed oil. Whole quinoa seed trials used 25-50 g/day (dry weight) over 12 weeks, with triglyceride-lowering effects seen at 50 g/day. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Omega-3 fatty acids, vitamin E, coenzyme Q10, plant sterols, flaxseed oil

Safety & Interactions

Quinoa seed oil is generally considered safe for topical and oral use at culinary doses, with no serious adverse events reported in available literature; however, individuals with known seed or plant-family (Amaranthaceae) allergies should exercise caution. Because the oil may additively lower LDL and triglycerides, concurrent use with statins, fibrates, or ezetimibe warrants monitoring for excessive lipid reduction or myopathy risk. Anticoagulant drug interactions are theoretically possible given the omega-3 fatty acid content (alpha-linolenic acid), which can mildly inhibit platelet aggregation; patients on warfarin or direct oral anticoagulants should consult a healthcare provider. Safety data in pregnancy and lactation is insufficient, and supplemental use beyond dietary amounts is not recommended in these populations without medical guidance.